TickerFacts.

Organon & Co. (OGN): Shareholders' Equity

Annual figures by period end, from SEC filings.

$752.00M
As of 2025-12-31
$1.01B
As of 2026-06-30
-32.8%
5-year compound annual growth
$7.04B2019-12-31: $7.04B2020-12-31: $5.49B2021-12-31: -$1.51B2022-12-31: -$892.00M2023-12-31: -$70.00M2024-12-31: $472.00M2025-12-31: $752.00M$752.00M
2019-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$752.00M+59.3%2026-02-24, Balance as of period end
2024-12-31$472.00Mn/m2026-02-24, Balance as of period end
2023-12-31-$70.00Mn/m2026-02-24, Balance as of period end
2022-12-31-$892.00Mn/m2025-11-10, Balance as of period end
2021-12-31-$1.51Bn/m2024-02-26, Balance as of period end
2020-12-31$5.49B-22.0%2023-02-27, Balance as of period end
2019-12-31$7.04Bn/a2022-03-21, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Organon & Co. (OGN)2025-12-31$752.00M+59.3%
BeOne Medicines Ltd. (ONC)2025-12-31$4.36B+30.9%
Elanco Animal Health Inc (ELAN)2025-12-31$6.55B+7.4%
Jazz Pharmaceuticals plc (JAZZ)2025-12-31$4.32B+5.5%
Perrigo Co PLC (PRGO)2025-12-31$2.94B-32.0%
Zoetis Inc. (ZTS)2025-12-31$3.33B-30.2%
Bausch Health Companies Inc. (BHC)2025-12-31$377.00Mn/m
Alnylam Pharmaceuticals, Inc. (ALNY)2025-12-31$789.18Mn/m
BioMarin Pharmaceutical Inc (BMRN)2025-12-31$6.09B+7.6%

Compare OGN, ONC, ELAN, JAZZ side by side · Screen every company in Pharmaceutical Preparations ↗